We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.9%
AUM
$798M
AUM Growth
-$17M
Cap. Flow
+$21.1M
Cap. Flow %
2.64%
Top 10 Hldgs %
54.49%
Holding
244
New
22
Increased
109
Reduced
71
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 27.62%
2 Consumer Discretionary 13.46%
3 Communication Services 12.65%
4 Healthcare 7.86%
5 Industrials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSEC icon
201
Prospect Capital
PSEC
$1.17B
$84.4K 0.01%
13,947
+112
+0.8% +$698
TLRY icon
202
Tilray
TLRY
$622M
$82.1K 0.01%
3,435
GALT icon
203
Galectin Therapeutics
GALT
$348M
$66.6K 0.01%
+34,707
New +$57.1K
IONQ icon
204
IonQ
IONQ
$16.6B
$58.8K 0.01%
+3,950
New +$62K
NIO icon
205
NIO
NIO
$11.9B
$48.2K 0.01%
5,328
-5,075
-49% -$56.5K
NKLA
206
DELISTED
Nikola Corporation Common Stock
NKLA
$35K ﹤0.01%
743
+240
+48% +$12.5K
PLTR icon
207
CALL
Palantir
PLTR
$413B
$32K ﹤0.01%
2,000
ABEV icon
208
Ambev
ABEV
$46.4B
$31.6K ﹤0.01%
12,235
SID icon
209
Companhia Siderúrgica Nacional
SID
$1.23B
$31.1K ﹤0.01%
13,000
-21,500
-62% -$55.1K
VERI icon
210
CALL
Veritone
VERI
$122M
$25.8K ﹤0.01%
+10,000
New +$33.2K
IBRX icon
211
ImmunityBio
IBRX
$8.1B
$25.3K ﹤0.01%
+14,950
New +$30K
LXRX icon
212
Lexicon Pharmaceuticals
LXRX
$1.1B
$23.9K ﹤0.01%
21,909
+1,103
+5% +$1.94K
POWW icon
213
Outdoor Holding Co
POWW
$247M
$20.2K ﹤0.01%
10,000
SNDL icon
214
Sundial Growers
SNDL
$320M
$20K ﹤0.01%
10,512
DNA icon
215
CALL
Ginkgo Bioworks
DNA
$521M
$18.1K ﹤0.01%
250
TELL
216
DELISTED
Tellurian Inc.
TELL
$16.4K ﹤0.01%
14,158
+3,000
+27% +$4.08K
DNA icon
217
Ginkgo Bioworks
DNA
$521M
$14.3K ﹤0.01%
197
+12
+6% +$959
SDC
218
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$8.73K ﹤0.01%
21,026
DMTK
219
DELISTED
DermTech, Inc. Common Stock
DMTK
$7.76K ﹤0.01%
5,386
+5,000
+1,295% +$12.5K
NCNA
220
NuCana
NCNA
$6.12M
$6.71K ﹤0.01%
2
CGC
221
Canopy Growth
CGC
$410M
$5.47K ﹤0.01%
+699
New +$4.28K
AIM
222
AIM ImmunoTech
AIM
$7.91M
$5.36K ﹤0.01%
118
SOFI icon
223
CALL
SoFi Technologies
SOFI
$23.7B
$4.79K ﹤0.01%
+600
New +$5.28K
INUV icon
224
Inuvo
INUV
$17M
$4.28K ﹤0.01%
2,000
VERI icon
225
Veritone
VERI
$122M
$1.85K ﹤0.01%
+716
New +$2.38K

Similar funds

Traynor Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Traynor Capital Management held 244 positions worth $798M, down 2.1% from $815M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Traynor Capital Management's Q3 2023 filing shows 22 new, 109 increased, 71 reduced and 17 closed positions. Its largest new stake was iShares Russell 1000 ETF: 2,306 shares worth $542K. The largest sale was Enphase Energy, an estimated $4.35M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Traynor Capital Management's largest Q3 2023 buy was iShares Russell 1000 ETF: 2,306 shares worth $542K.
  • Traynor Capital Management added most to Novo Nordisk in Q3 2023, an estimated $4.55M increase.
  • Traynor Capital Management's biggest Q3 2023 reduction was Enphase Energy, cutting an estimated $4.35M.
  • Traynor Capital Management fully exited Invesco S&P 500 High Dividend Low Volatility ETF in Q3 2023, selling an estimated $948K.
  • Traynor Capital Management's ten largest holdings make up 54% of its $798M portfolio in Q3 2023.
  • Traynor Capital Management opened 22 new positions and closed 17 in Q3 2023.
  • Traynor Capital Management's portfolio value fell 2.1% quarter-over-quarter to $798M.

Based on Traynor Capital Management's 13F filing for Q3 2023, filed 16 Oct 2023.